Hematology/Oncology News

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, explains why it is important to consider how myeloproliferative neoplasms treatment will affect a patient's quality of life.

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, discussed the different approaches to treating different types of MPNs, like myelofibrosis, essential thrombocythemia and polycythemia vera.

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, highlighted recent developments and available treatments in myeloproliferative neoplasms care.

IceCure Medical has received marketing authorization from the FDA for its next-generation single probe cryoablation system, the company announced in a press release.

Certain physical exercises may prevent nerve damage caused by chemotherapy among individuals being treated for cancer, results of a randomized study published in JAMA Internal Medicine showed.

Black women have higher rates of early death from tubo-ovarian, cervical and uterine cancers compared with women of other races and ethnicities, data show.

Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.

Christian Rolfo, MD, PhD, MBA, will be the director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, as of Aug. 15.

In this video, Ronny Drapkin, MD, discusses the importance of increasing ovarian cancer awareness in PCPs and OB/GYNs.

In this video, Ronny Drapkin, MD, discusses identifying patients at heightened risk for ovarian cancer.